Maurer, Florian PShubladze, NataliaKalmambetova, GulmiraFelker, IrinaKuchukhidze, GiorgiDrobniewski, FrancisYedilbayev, AskarEhsani, SoudehEuropean Laboratory Initiative on TB, HIV and Viral HepatitisAvellón, Ana2022-09-212022-09-212021-06Euro Surveill. 2021 Jun;26(24):2100426.http://hdl.handle.net/20.500.12105/15004We assessed the impact of COVID-19 on diagnostic services for tuberculosis (TB) by national reference laboratories in the WHO European Region. Of 35 laboratories, 30 reported declines in TB sample numbers, amounting up to > 50% of the pre-COVID-19 volumes. Sixteen reported reagent or consumable shortages. Nineteen reallocated ressources to SARS-CoV-2 testing, resulting in an overall increase in workload, largely without a concomitant increase in personnel (n = 14). This poses a risk to meeting the 2025 milestones of the End TB Strategy.engVoRhttp://creativecommons.org/licenses/by-nc-nd/4.0/PCRSARS-CoV-2DiagnosticsCOVID-19TuberculosisCOVID-19 TestingHumansLaboratoriesPandemicsSARS-CoV-2World Health OrganizationAttribution-NonCommercial-NoDerivatives 4.0 Internacional341426512624210042610.2807/1560-7917.ES.2021.26.24.21004261560-7917Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletinopen access